Additionally, a study by Farooq et al. showed that CXCR2−/− or anti-CXCR2 antiserum-treated mice had lower symptom scores for DSS-induced colitis, with significantly lower polymorphonuclear neutrophil (PMN) infiltration [76]. The gene discussed is CXCR2; the disease is colitis.